WEST PHARMACEUTICAL SERVICES, INC. Treasury Stock, Common, Value
WEST PHARMACEUTICAL SERVICES, INC. (WST) had Treasury Stock, Common, Value of $1.51 billion as of 2026-06-30, per its 10-Q filed 2026-07-23.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:TreasuryStockCommonValue · last filed 2026-07-23
- 2026-06-30: Treasury Stock, Common, Value $1.51B.
- 2026-03-31: Treasury Stock, Common, Value $1.38B.
- 2025-12-31: Treasury Stock, Common, Value $1.11B.
- 2025-09-30: Treasury Stock, Common, Value $1.13B.
| Period end | Treasury Stock, Common, Value |
|---|---|
| 2026-06-30 | $1.51B 10-Q · filed 2026-07-23 |
| 2026-03-31 | $1.38B 10-Q · filed 2026-04-23 |
| 2025-12-31 | $1.11B 10-Q · filed 2026-07-23 |
| 2025-09-30 | $1.13B 10-Q · filed 2025-10-23 |
| 2025-06-30 | $1.14B 10-Q · filed 2025-07-24 |
| 2025-03-31 | $1.16B 10-Q · filed 2025-04-24 |
| 2024-12-31 | $1.06B 10-K · filed 2026-02-17 |
| 2024-09-30 | $1.01B 10-Q · filed 2024-10-24 |
| 2024-06-30 | $979.50M 10-Q · filed 2024-07-25 |
| 2024-03-31 | $825.20M 10-Q · filed 2024-04-25 |
| 2023-12-31 | $637.60M 10-K · filed 2025-02-18 |
| 2023-09-30 | $466.10M 10-Q · filed 2023-10-26 |
| 2023-06-30 | $501.40M 10-Q · filed 2023-07-27 |
| 2023-03-31 | $369.20M 10-Q · filed 2023-04-27 |
| 2022-12-31 | $370.90M 10-K · filed 2024-02-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DEXCOM INC (DXCM) | United States | $33.004B | 25.42 |
| Solventum Corp (SOLV) | United States | $15.085B | 9.16 |
| Penumbra Inc (PEN) | United States | $12.596B | 77.33 |
| BAXTER INTERNATIONAL INC (BAX) | United States | $12.139B | -10.35 |
| GLOBUS MEDICAL INC (GMED) | United States | $9.977B | 20.03 |
| INSULET CORP (PODD) | United States | $9.420B | 28.12 |
| GLAUKOS Corp (GKOS) | United States | $9.135B | -43.73 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |